Skip to main content

Table 6 Performance re-evaluation: linear regression on results from bioanalytical screening (BEQ) of 25 pig meat (pork) samples for PCDD/Fs and DL-PCBs, and from GC/HRMS analysis (TEQ), followed by calculation of the respective cut-off concentrations, and of α- and ß-errors (false-noncompliant and false-compliant rates) [18, 22]

From: Bioanalytical screening of low levels of dioxins and dioxin-like PCBs in pig meat (pork) for checking compliance with EU maximum and action levels using highly sensitive “third generation” recombinant H4L7.5c2 rat hepatoma cells

Parameter

Unit

Symbol

PCDD/Fs (ML)

PCDD/Fs (AL)

DL-PCBs

PCDD/Fs + DL-PCBs

Number of samples

 

N

19

19

19

19

Number of analyses per samplea

 

m

1 (6 × 2)

1 (6 × 2)

1 (6 × 2)

1 (6 × 2)

Number of analyses (total)

 

n

25

25

25

25

Calibrated range

pg TEQ/g fat

R

0.07–2.86

0.07–2.86

0.23–3.59

0.30–5.67

Slope, calibration line

 

b

0.904

0.904

0.722

0.891

Standard error of the slope

 

sb

0.050

0.050

0.032

0.029

y-intercept, calibration line

pg BEQ/g fat

a

0.092

0.092

0.134

− 0.060

Standard error of the y-intercept

pg BEQ/g fat

sa

0.075

0.075

0.063

0.093

Coefficient of correlation

 

r

0.9665

0.9665

0.9784

0.9884

Critical value for r (df = n − 2, p = 0.05, two-sided)

 

critr

0.3961

0.3961

0.3961

0.3961

Square coefficient of correlation

 

r2

0.9342

0.9342

0.9573

0.9770

GC/HRMS decision limitb

pg TEQ/g fat

DL

1.2

0.90

0.60

1.50

BEQ concentration at DL

pg BEQ/g fat

yDL

1.2

0.91

0.57

1.28

Residual standard deviationc

pg BEQ/g fat

syx

0.2326

0.2326

0.1504

0.2155

Relative syx at yDL (precisionc)

%

syx,rel

19.8

25.7

26.5

16.9

Cut-off concentration

pg BEQ/g fat

yCut-off

0.70

0.42

0.24

0.82

α-Error (false-noncompliant rate)d,e

%

α

17 / 0

38 / 24

0 / 0

10 / 8

ß-Error (false-compliant rate)d

%

ß

0

0

0

0

Maximum level

pg TEQ/g fat

ML

1.0

1.25

Action level

pg TEQ/g fat

AL

0.75

0.50

  1. aSix out of 19 samples were analysed in duplicate
  2. bML, or AL, plus the expanded measurement uncertainty U (here: U = 20%)
  3. cWithin-laboratory reproducibility conditions
  4. dFrom application of the cut-off value established during initial validation
  5. eBased on results potentially noncompliant from screening/based on all screening results